Category : Search result: Sonipat pharma trader


Sonipat Trader Held in Rs 118 Cr GST Evasion Case

CGST Rohtak arrests Sonipat pharma trader Pawel Garg for alleged GST evasion of Rs 21.30 crore on sales of Rs 118.49 crore. Raid uncovers unaccounted transactions. Read the full details.

Rajit Kapur's Malayalam comeback after 25 years

National Award-winning actor Rajit Kapur discusses his return to Malayalam cinema with the medical drama 'Pharma', his role as Dr. Rajiv Rao, and the rise of South Indian OTT content.

Master the Trader's Trinity for Stock Market Success

Discover the three essential principles—Strategy, Risk Management, and Psychology—that form the foundation for sustainable trading success in India's rapidly evolving stock market. Learn how to navigate volatility and build discipline.

Sun Pharma Shares Fall 3% Post-US FDA Inspection

Sun Pharmaceutical shares fell over 3% after a US FDA inspection at its Baska plant. The inspection concluded with 3 observations. Get the full details on the market impact and company's response.

Odisha Approves Pharma & Medtech Policy 2025

Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.

Granules India's US facility passes FDA GMP inspection

Granules India's US subsidiary, Granules Consumer Health LLC, successfully cleared a USFDA GMP inspection with zero observations. This marks a significant achievement for the Hyderabad-based pharma major's OTC product operations in America.

Haryana woman held for killing 3 girls, murders son

A Haryana woman arrested for the murder of three young girls confessed she was driven by jealousy of their beauty. In a shocking twist, she also killed her own son to avoid suspicion. Details inside.

Sun Pharma's Ilumya for Psoriasis Launched in India

Sun Pharma introduces its global biologic Ilumya for moderate-to-severe plaque psoriasis in India. Backed by Phase-3 data, it offers long-lasting clearance with a strong safety profile. Learn more about this targeted therapy.

Page 1 of 4